Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
ALL DEFINITIONS

HER2-Positive Breast Cancer

Definition

HER2-positive breast cancer is a subtype of breast cancer characterized by the overexpression of human epidermal growth factor receptor 2 (HER2) protein on the surface of cancer cells. This overexpression promotes the growth and division of cancer cells, making HER2-positive breast cancers more aggressive and fast-growing compared to other subtypes.

Related Specialists

Showing 3 of 33
  • Neal Fischbach

    MD
  • Michael DiGiovanna

    MD, PhD
  • Kathleen Fenn

    MD
More Related Specialists

Related Clinical Trials

Showing 2 of 7
  • QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

    • Breast Cancer
    • A Randomized, Multicenter, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects With Residual Disease or High-Risk PCR After Both Neoadjuvant and Postoperative Adjuvant Trastuzumab-based Therapy (FLAMINGO-01)

      • Breast Cancer
      More Related Clinical Trials
      • About Us
      • Contact Us
      • Donate
      • Referring Doctors
      • Clinical Keywords

      333 Cedar St.

      New Haven, CT 06510

      • Yale School of Medicine
      • Yale University
      • Terms & Privacy Policies
      • Accessibility at YSM
      • Patient Rights
      • HIPAA at Yale
      • Non-discrimination Statement
      Copyright 2026 Yale Medicine